Histologic Variants of Urothelial Bladder Cancer and Nonurothelial Histology in Bladder Cancer

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2009 Dec 19

PMID 20019984

Citations 84

Authors

Venu Chalasani

Joseph L Chin

Jonathan I Izawa

Affiliations

Soon will be listed here.

Abstract

Bladder cancer can be classified histologically as urothelial or non-urothelial. Urothelial cancer has a propensity for divergent differentiation, which has increasingly been recognized in recent years due to heightened awareness and improved immunohistochemistry techniques. Furthermore, the recent World Health Organization classification of urothelial cancers improved clarity on this issue, with its listing of 13 histologic variants of urothelial cancer. The divergent differentiation patterns include, amongst others, squamous, glandular, micropapillary, nested, lymphepithelioma-like, plasmacytoid and sarcomatoid variants of urothelial cancer. Attempts to quantify the amount of divergent differentiation present, such as using the nonconventional differentiation number, have been made recently, which will improve the ability to compare publications from different centres. Genetic-based studies have indicated that the histologic variants of urothelial cancer arise from a common clonal precursor. Mostly, the current evidence suggests that urothelial cancer with divergent differentiation has a worse prognosis when compared with pure urothelial cancer. This article will review the current literature on variant histologies of urothelial cancer, and well as new developments in pure squamous cell carcinoma, small cell carcinoma and adenocarcinoma of the bladder.

Citing Articles

Endometriosis-associated primary clear cell adenocarcinoma of the urinary bladder: A case report and literature review.

Singh M, Raver M, DeAgresta B, Della Pia A, Saxena S, Klobocista M Urol Case Rep. 2025; 58():102916.

PMID: 39811563 PMC: 11732500. DOI: 10.1016/j.eucr.2024.102916.

Integrated enhanced recovery after surgery protocol in radical cystectomy for bladder tumour-A retroprospective study.

Ashraf W, Hamid A, Malik S, Khawaja R, Para S, Wani M BJUI Compass. 2024; 5(11):1069-1080.

PMID: 39539563 PMC: 11557271. DOI: 10.1002/bco2.438.

Comprehensive Analysis of the Significance of Breast Cancer Gene 1 (BRCA-1) in Bladder Cancer.

Zhang X, Tao X, Zhou Y, Shi G, Wang T Cancer Manag Res. 2024; 16:1305-1319.

PMID: 39372705 PMC: 11451393. DOI: 10.2147/CMAR.S467817.

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States.

Li A, Wu M, Xie O, Xiang H, Meng K, Tan C Front Immunol. 2024; 15:1464092.

PMID: 39315111 PMC: 11416998. DOI: 10.3389/fimmu.2024.1464092.

PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.

Martini D, Case K, Gratz D, Pellegrini K, Beagle E, Schneider T Cancer. 2024; 130(21):3658-3670.

PMID: 38959291 PMC: 11464191. DOI: 10.1002/cncr.35465.

References

Ghoneim M, El-Mekresh M, el-Baz M, Ashamallah A . Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol. 1997; 158(2):393-9. View

Reuter V . The pathology of bladder cancer. Urology. 2006; 67(3 Suppl 1):11-7. DOI: 10.1016/j.urology.2006.01.037. View

Spiess P, Kassouf W, Steinberg J, Tuziak T, Hernandez M, Tibbs R . Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol. 2007; 25(1):38-45. DOI: 10.1016/j.urolonc.2006.02.003. View

Martin J, Jenkins B, Zuk R, Blandy J, Baithun S . Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol. 1989; 42(3):250-3. PMC: 1141863. DOI: 10.1136/jcp.42.3.250. View

Rogers C, Palapattu G, Shariat S, Karakiewicz P, Bastian P, Lotan Y . Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol. 2006; 175(6):2048-53. DOI: 10.1016/S0022-5347(06)00317-X. View

Black P, Brown G, Grossman H, Dinney C . Neoadjuvant chemotherapy for bladder cancer. World J Urol. 2006; 24(5):531-42. DOI: 10.1007/s00345-006-0113-z. View

Sung M, Wang M, MacLennan G, Eble J, Tan P, Lopez-Beltran A . Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol. 2007; 211(4):420-30. DOI: 10.1002/path.2129. View

Tsili A, Giannakis D, Sofikitis N, Tsampoulas K . Small cell carcinoma of the urinary bladder: virtual CT cystoscopic findings. J Postgrad Med. 2009; 55(1):33-4. DOI: 10.4103/0022-3859.48437. View

Mukesh M, Cook N, Hollingdale A, Ainsworth N, Russell S . Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int. 2008; 103(6):747-52. DOI: 10.1111/j.1464-410X.2008.08241.x. View

10.

Fadare O, Renshaw I, Rubin C . Pleomorphic lymphoepithelioma-like carcinoma of the urinary bladder. Int J Clin Exp Pathol. 2008; 2(2):194-9. PMC: 2583638. View

11.

Drew P, Furman J, Civantos F, MURPHY W . The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol. 1996; 9(10):989-94. View

12.

Wright J, Porter M, Li C, Lange P, Lin D . Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 2006; 107(4):721-8. DOI: 10.1002/cncr.22059. View

13.

Johansson S, Borghede G, Holmang S . Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol. 1999; 161(6):1798-802. DOI: 10.1016/s0022-5347(05)68807-6. View

14.

Kamat A, Gee J, Dinney C, Grossman H, Swanson D, Millikan R . The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol. 2006; 175(3 Pt 1):881-5. DOI: 10.1016/S0022-5347(05)00423-4. View

15.

Wright J, Black P, Brown G, Porter M, Kamat A, Dinney C . Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol. 2007; 178(6):2302-6. DOI: 10.1016/j.juro.2007.08.038. View

16.

Domanowska E, Jozwicki W, Domaniewski J, Golda R, Skok Z, Wisniewska H . Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize. Hum Pathol. 2007; 38(5):741-6. DOI: 10.1016/j.humpath.2006.11.001. View

17.

Siefker-Radtke A, Dinney C, Abrahams N, Moran C, Shen Y, Pisters L . Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol. 2004; 172(2):481-4. DOI: 10.1097/01.ju.0000132413.85866.fc. View

18.

Amin M, Ro J, El-Sharkawy T, Lee K, Troncoso P, Silva E . Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994; 18(12):1224-32. DOI: 10.1097/00000478-199412000-00005. View

19.

Kassouf W, Spiess P, Siefker-Radtke A, Swanson D, Grossman H, Kamat A . Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer. 2007; 110(4):764-9. DOI: 10.1002/cncr.22853. View

20.

Holmang S, Johansson S . The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis. Scand J Urol Nephrol. 2001; 35(2):102-5. DOI: 10.1080/003655901750170425. View